Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Briacell Therapeutics Corp. T.BCT

Alternate Symbol(s):  BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops immunotherapies to transform cancer care. The Company’s lead drug candidate, Bria-IMT, is a cell-based patented immunotherapy that stimulates a patient’s own cancer fighting cells to attack and destroy breast cancer tumors. The Company is advancing its targeted immunotherapy program by prioritizing a Phase II clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor. The Company is focused on conducting a Phase I/IIa clinical trial of Bria-IMT in a combination study with Incyte’s immune PD-1 inhibitor, retifanlimab, in advanced breast cancer. The Company is also developing Bria-OTS, an off-the-shelf personalized approach to whole cell cancer immunotherapy. The Bria-OTS immunotherapy is based on a patient’s HLA-type. Its pipeline also includes Bria-Pros, Bria-Lung, Bria-Mel and sCD80, which are in development to treat various cancers.


TSX:BCT - Post by User

Bullboard Posts
Post by Charttraderon Mar 30, 2016 2:51pm
46 Views
Post# 24712208

RYU.VN has the recipe for success

RYU.VN has the recipe for successRYU.VN is trading way below their market values. Here are some key points to consider.

They have a brick and mortar store with unbelievable start up sales.

RYU is ranked 6th in the diversified industries category on the TSX Venture top 50.

A truly invested CEO and management team who hold a large amount of the company shares within.

They have built a team that has many years of experience with some of the top retailers including LuLu Lemon, Arc’teryx, The North Face, Vans, Eddie Bauer, Ralph Lauren, Marmot, 
and many more.

Projected sales of $112M by 2025.

IMO this is a sleeping giant which will awaken any moment.

Buy or don’t buy, up to you, but you should put this on your watch list.

Kind regards,

Charttrader

Bullboard Posts